Supplemental oxygen reduces intimal hyperplasia after intraarterial stenting in the rabbit

Alexander S. Tretinyak, Eugene S Lee, Kristina M. Uema, Alexandre C. D'Audiffret, Michael P. Caldwell, Steven M. Santilli

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Hypothesis: Supplemental oxygen can reduce intimal hyperplasia (IH) after stent deployment in a rabbit model. Background: Endovascular stent placement is technically feasible, but long-term durability in vessels outside the aortoiliac system is compromised with postinterventional IH, which causes restenosis and failure of the arterial conduit. Methods: Groups (n = 4 to 6) of female New Zealand white rabbits underwent placement of a 3-mm intraaortic stent with laparotomy and were placed in either normoxic (21% inspired oxygen concentration) or supplemental-oxygen (40% inspired oxygen concentration) environments for 0, 7, 14, and 28 days. The transarterial wall oxygen gradient was measured at 0, 7, and 28 days with an oxygen microelectrode. 5-Bromo-2'deoxyuridine (BrdU) was injected into the peritoneum before death to assess cellular proliferation. Aortic specimens were harvested en bloc and sectioned for analysis of cellular proliferation and intimal thickness. Results: Intraaortic stent placement significantly decreased the transarterial wall oxygen gradient in the outer 70% of the vessel wall and was easily reversed at 7, 14, and 28 days with application of supplemental oxygen. Cellular proliferation was significantly decreased at 14 days (0.5% ± 0.001% versus 2.3% ± 0.002%; P < .001) and 28 days (0.4% ± 0.001% versus 1.0% ± 0.001%; P< .025) as measured with count of nuclei staining for 5-Bromo-2'deoxyuridine in the intima and media. Intimal thickness was significantly decreased at 28 days in oxygen-supplemented rabbits (intimai area/medial area = 0.50 ± 0.07) as compared with controls (intimal area/medial area = 0.89 ± 0.11; P < .025). Conclusion: This study shows the ability of supplemental oxygen to reverse arterial wall hypoxia, decrease cellular proliferation, and control IH at the deployment site of an intraarterial stent in a rabbit model. Forty-percent supplemental oxygen suppresses IH by 44% at 28 days as compared with normoxic control values. Cellular proliferation is reduced four-fold at 14 days and two-fold at 28 days in oxygen-supplemented rabbits as compared with control media after deployment. The clinical implications of these findings are significant, especially as the role of endovascular interventions continues to expand.

Original languageEnglish (US)
Pages (from-to)982-987
Number of pages6
JournalJournal of Vascular Surgery
Volume35
Issue number5
DOIs
StatePublished - May 2002
Externally publishedYes

Fingerprint

Tunica Intima
Hyperplasia
Oxygen
Rabbits
Stents
Cell Proliferation
Bromodeoxyuridine
Peritoneum
Microelectrodes
Laparotomy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Tretinyak, A. S., Lee, E. S., Uema, K. M., D'Audiffret, A. C., Caldwell, M. P., & Santilli, S. M. (2002). Supplemental oxygen reduces intimal hyperplasia after intraarterial stenting in the rabbit. Journal of Vascular Surgery, 35(5), 982-987. https://doi.org/10.1067/mva.2002.123090

Supplemental oxygen reduces intimal hyperplasia after intraarterial stenting in the rabbit. / Tretinyak, Alexander S.; Lee, Eugene S; Uema, Kristina M.; D'Audiffret, Alexandre C.; Caldwell, Michael P.; Santilli, Steven M.

In: Journal of Vascular Surgery, Vol. 35, No. 5, 05.2002, p. 982-987.

Research output: Contribution to journalArticle

Tretinyak, AS, Lee, ES, Uema, KM, D'Audiffret, AC, Caldwell, MP & Santilli, SM 2002, 'Supplemental oxygen reduces intimal hyperplasia after intraarterial stenting in the rabbit', Journal of Vascular Surgery, vol. 35, no. 5, pp. 982-987. https://doi.org/10.1067/mva.2002.123090
Tretinyak, Alexander S. ; Lee, Eugene S ; Uema, Kristina M. ; D'Audiffret, Alexandre C. ; Caldwell, Michael P. ; Santilli, Steven M. / Supplemental oxygen reduces intimal hyperplasia after intraarterial stenting in the rabbit. In: Journal of Vascular Surgery. 2002 ; Vol. 35, No. 5. pp. 982-987.
@article{5d3988592369487794bbde067375017d,
title = "Supplemental oxygen reduces intimal hyperplasia after intraarterial stenting in the rabbit",
abstract = "Hypothesis: Supplemental oxygen can reduce intimal hyperplasia (IH) after stent deployment in a rabbit model. Background: Endovascular stent placement is technically feasible, but long-term durability in vessels outside the aortoiliac system is compromised with postinterventional IH, which causes restenosis and failure of the arterial conduit. Methods: Groups (n = 4 to 6) of female New Zealand white rabbits underwent placement of a 3-mm intraaortic stent with laparotomy and were placed in either normoxic (21{\%} inspired oxygen concentration) or supplemental-oxygen (40{\%} inspired oxygen concentration) environments for 0, 7, 14, and 28 days. The transarterial wall oxygen gradient was measured at 0, 7, and 28 days with an oxygen microelectrode. 5-Bromo-2'deoxyuridine (BrdU) was injected into the peritoneum before death to assess cellular proliferation. Aortic specimens were harvested en bloc and sectioned for analysis of cellular proliferation and intimal thickness. Results: Intraaortic stent placement significantly decreased the transarterial wall oxygen gradient in the outer 70{\%} of the vessel wall and was easily reversed at 7, 14, and 28 days with application of supplemental oxygen. Cellular proliferation was significantly decreased at 14 days (0.5{\%} ± 0.001{\%} versus 2.3{\%} ± 0.002{\%}; P < .001) and 28 days (0.4{\%} ± 0.001{\%} versus 1.0{\%} ± 0.001{\%}; P< .025) as measured with count of nuclei staining for 5-Bromo-2'deoxyuridine in the intima and media. Intimal thickness was significantly decreased at 28 days in oxygen-supplemented rabbits (intimai area/medial area = 0.50 ± 0.07) as compared with controls (intimal area/medial area = 0.89 ± 0.11; P < .025). Conclusion: This study shows the ability of supplemental oxygen to reverse arterial wall hypoxia, decrease cellular proliferation, and control IH at the deployment site of an intraarterial stent in a rabbit model. Forty-percent supplemental oxygen suppresses IH by 44{\%} at 28 days as compared with normoxic control values. Cellular proliferation is reduced four-fold at 14 days and two-fold at 28 days in oxygen-supplemented rabbits as compared with control media after deployment. The clinical implications of these findings are significant, especially as the role of endovascular interventions continues to expand.",
author = "Tretinyak, {Alexander S.} and Lee, {Eugene S} and Uema, {Kristina M.} and D'Audiffret, {Alexandre C.} and Caldwell, {Michael P.} and Santilli, {Steven M.}",
year = "2002",
month = "5",
doi = "10.1067/mva.2002.123090",
language = "English (US)",
volume = "35",
pages = "982--987",
journal = "Journal of Vascular Surgery",
issn = "0741-5214",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Supplemental oxygen reduces intimal hyperplasia after intraarterial stenting in the rabbit

AU - Tretinyak, Alexander S.

AU - Lee, Eugene S

AU - Uema, Kristina M.

AU - D'Audiffret, Alexandre C.

AU - Caldwell, Michael P.

AU - Santilli, Steven M.

PY - 2002/5

Y1 - 2002/5

N2 - Hypothesis: Supplemental oxygen can reduce intimal hyperplasia (IH) after stent deployment in a rabbit model. Background: Endovascular stent placement is technically feasible, but long-term durability in vessels outside the aortoiliac system is compromised with postinterventional IH, which causes restenosis and failure of the arterial conduit. Methods: Groups (n = 4 to 6) of female New Zealand white rabbits underwent placement of a 3-mm intraaortic stent with laparotomy and were placed in either normoxic (21% inspired oxygen concentration) or supplemental-oxygen (40% inspired oxygen concentration) environments for 0, 7, 14, and 28 days. The transarterial wall oxygen gradient was measured at 0, 7, and 28 days with an oxygen microelectrode. 5-Bromo-2'deoxyuridine (BrdU) was injected into the peritoneum before death to assess cellular proliferation. Aortic specimens were harvested en bloc and sectioned for analysis of cellular proliferation and intimal thickness. Results: Intraaortic stent placement significantly decreased the transarterial wall oxygen gradient in the outer 70% of the vessel wall and was easily reversed at 7, 14, and 28 days with application of supplemental oxygen. Cellular proliferation was significantly decreased at 14 days (0.5% ± 0.001% versus 2.3% ± 0.002%; P < .001) and 28 days (0.4% ± 0.001% versus 1.0% ± 0.001%; P< .025) as measured with count of nuclei staining for 5-Bromo-2'deoxyuridine in the intima and media. Intimal thickness was significantly decreased at 28 days in oxygen-supplemented rabbits (intimai area/medial area = 0.50 ± 0.07) as compared with controls (intimal area/medial area = 0.89 ± 0.11; P < .025). Conclusion: This study shows the ability of supplemental oxygen to reverse arterial wall hypoxia, decrease cellular proliferation, and control IH at the deployment site of an intraarterial stent in a rabbit model. Forty-percent supplemental oxygen suppresses IH by 44% at 28 days as compared with normoxic control values. Cellular proliferation is reduced four-fold at 14 days and two-fold at 28 days in oxygen-supplemented rabbits as compared with control media after deployment. The clinical implications of these findings are significant, especially as the role of endovascular interventions continues to expand.

AB - Hypothesis: Supplemental oxygen can reduce intimal hyperplasia (IH) after stent deployment in a rabbit model. Background: Endovascular stent placement is technically feasible, but long-term durability in vessels outside the aortoiliac system is compromised with postinterventional IH, which causes restenosis and failure of the arterial conduit. Methods: Groups (n = 4 to 6) of female New Zealand white rabbits underwent placement of a 3-mm intraaortic stent with laparotomy and were placed in either normoxic (21% inspired oxygen concentration) or supplemental-oxygen (40% inspired oxygen concentration) environments for 0, 7, 14, and 28 days. The transarterial wall oxygen gradient was measured at 0, 7, and 28 days with an oxygen microelectrode. 5-Bromo-2'deoxyuridine (BrdU) was injected into the peritoneum before death to assess cellular proliferation. Aortic specimens were harvested en bloc and sectioned for analysis of cellular proliferation and intimal thickness. Results: Intraaortic stent placement significantly decreased the transarterial wall oxygen gradient in the outer 70% of the vessel wall and was easily reversed at 7, 14, and 28 days with application of supplemental oxygen. Cellular proliferation was significantly decreased at 14 days (0.5% ± 0.001% versus 2.3% ± 0.002%; P < .001) and 28 days (0.4% ± 0.001% versus 1.0% ± 0.001%; P< .025) as measured with count of nuclei staining for 5-Bromo-2'deoxyuridine in the intima and media. Intimal thickness was significantly decreased at 28 days in oxygen-supplemented rabbits (intimai area/medial area = 0.50 ± 0.07) as compared with controls (intimal area/medial area = 0.89 ± 0.11; P < .025). Conclusion: This study shows the ability of supplemental oxygen to reverse arterial wall hypoxia, decrease cellular proliferation, and control IH at the deployment site of an intraarterial stent in a rabbit model. Forty-percent supplemental oxygen suppresses IH by 44% at 28 days as compared with normoxic control values. Cellular proliferation is reduced four-fold at 14 days and two-fold at 28 days in oxygen-supplemented rabbits as compared with control media after deployment. The clinical implications of these findings are significant, especially as the role of endovascular interventions continues to expand.

UR - http://www.scopus.com/inward/record.url?scp=0036581368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036581368&partnerID=8YFLogxK

U2 - 10.1067/mva.2002.123090

DO - 10.1067/mva.2002.123090

M3 - Article

C2 - 12021715

AN - SCOPUS:0036581368

VL - 35

SP - 982

EP - 987

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

SN - 0741-5214

IS - 5

ER -